← Leaderboards
Raj K. Singh
Diversified Scientific, Inc.
$3,835,518
Attributed
$7,530,318
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,530,318 · 8
By mechanism
U01$4,475,190 · 1
R44$2,169,596 · 3
R43$885,532 · 4
Top collaborators
- Jake Yue Chen7 shared
- Xiangqin Cui7 shared
- Anita Borton Hjelmeland7 shared
- Christopher D Willey7 shared
- G. Yancey Gillespie5 shared
Others in their field
Top investigators on “Extracellular Matrix”
- Valerie Marie Weaver · University Of California, San Francisco$23,238,959
- Naftali Kaminski · Yale University$23,053,857
- Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
- Paul Wesley Noble · Yale University$20,772,493
- Martin A. Schwartz · Yale University$19,622,975
- Buddy D Ratner · University Of Washington$19,514,039
Research focus
Extracellular MatrixCell ProliferationExhibitsGrowth FactorTumorIn VitroBiological ModelsGrowthDrug DiscoveryExtracellular Matrix ProteinsReproducibilityCell LineGenomicsPropertyEnvironmentPre-ClinicalCancer BiologyGrantBiologicalAnticancer ResearchBiologyBrain Neoplasms3-DimensionalDrug Testing
Grant awards (20)
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$702,000
U01 · FY2022 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$333,751
U01 · FY2022 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$790,576
U01 · FY2021 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$333,751
U01 · FY2021 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$827,700
U01 · FY2020 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$746,835
U01 · FY2019 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$740,577
U01 · FY2018 · CA
New High Throughput Anti-Tumor Drug Screening System$156,981
R43 · FY2014 · CA · contact PI
New In Vitro Human Liver Toxicity Bioassay System$297,246
R44 · FY2013 · ES · contact PI
New In Vitro Human Liver Toxicity Bioassay System$441,820
R44 · FY2012 · ES · contact PI
New In Vitro Human Liver Toxicity Bioassay System$130,000
R43 · FY2010 · ES · contact PI
New In Vitro 3D Functional Model of Tumorigenesis$362,163
R44 · FY2007 · CA · contact PI
New In Vitro 3D Functional Model of Tumorigenesis$332,083
R44 · FY2006 · CA · contact PI
NEW IN VITRO 3D FUNCTIONAL MODEL OF TUMORIGENESIS$73,601
R43 · FY2004 · CA
NEW IN VITRO 3D FUNCTIONAL MODEL OF TUMORIGENESIS$26,401
R43 · FY2004 · CA
Design &Discovery of Novel Antimetastatic MMP Inhibitor$248,564
R43 · FY2003 · CA
Design &Discovery of Novel Antimetastatic MMP Inhibitor$249,985
R43 · FY2002 · CA
A Defined Biomatrix Model for Human Vascular Studies$199,992
R44 · FY2002 · HL
A Defined Biomatrix Model for Human Vascular Studies$129,619
R44 · FY2002 · HL
A Defined Biomatrix Model for Human Vascular Studies$406,673
R44 · FY2001 · HL